| Literature DB >> 29522459 |
Anne-Marie Caminade1,2, Jean-Pierre Majoral3,4.
Abstract
Among the six Critical Nanoscale Design Parameters (CNDPs) proposed by Prof. Donald A. Tomalia, this review illustrates the influence of the sixth one, which concerns the elemental composition, on the properties of dendrimers. After a large introduction that summarizes different types of dendrimers that have been compared with PolyAMidoAMine (PAMAM) dendrimers, this review will focus on the properties of positively and negatively charged phosphorhydrazone (PPH) dendrimers, especially in the field of biology, compared with other types of dendrimers, in particular PAMAM dendrimers, as well as polypropyleneimine (PPI), carbosilane, and p-Lysine dendrimers.Entities:
Keywords: biological properties; chemical composition; dendrimers; phosphorhydrazone
Mesh:
Substances:
Year: 2018 PMID: 29522459 PMCID: PMC6017475 DOI: 10.3390/molecules23030622
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure of different types of third-generation dendrimers.
Figure 2Water-soluble third-generation phosphorus dendrimer with 48 tertiary ammonium terminal functions.
Figure 3First-generation phosphorhydrazone dendrimer with azabisphosphonate terminal functions (ABP).
Figure 4Efficiency of the activation of monocytes, depending on the internal structure of the dendrimers (0: no activation; ++: good activation; +++: the highest activation).
Types of dendrimers, with the nature and number of their terminal functions, used for comparison in different biological experiments. The most efficient compound for each experiment is highlighted in red.
| PPH | PAMAM | PPI | PCSi | P-Lys | Experiment | Ref. |
|---|---|---|---|---|---|---|
| -NEt2H)96 | -NH3)64 | -NMe3)24 | Clinical tests | [ | ||
| -NEt2H)96 | Transfection | [ | ||||
| -NH3)32/ | -NMe3)8 | Protection SiRNA 1 | [ | |||
| -NH3)32/ | -NMe3)8 | Carrier of Si RNA | [ | |||
| -NEt2H)96 | -NH3)16 | Peptide aggregation scavenger | [ | |||
| -NH3)64/ | -NH3)16 | Interaction with heparin | [ | |||
| -NEt2H)48/ | Decrease ROS 2 levels | [ | ||||
| (PO3HNa)2]8 | Against RA 3 | [ | ||||
| (PO3HNa)2]8 | (PO3HNa)2]8 | (PO3HNa)2]8 | (PO3HNa)2]8 | Activation of monocytes | [ |
1 Small interfering RNA. 2 Reactive Oxygen Species. 3 Rheumatoid Arthritis. 4 Same efficiency with PPH (PO3HNa)2]8 [50].